Nanotechnology: The challenge of regulating known unknowns

Research output: Contribution to journalArticlepeer-review


Media reports of the health hazards posed by nano-sized particles (NSPs) have turned a white hot spotlight on the risks of nanotechnology. Worried about the risks posed to workers producing nano-materials, the Washington Post has labeled nanotechnology a "seat-of-the-pants occupational health experiment." This article examines our emerging knowledge base about the hazards of two types of exposure: inhalation of NSPs and topical application of products containing NSPs. It argues that a clear-eyed evaluation of the benefits and risks of nanotechnology is made extremely difficult by the marriage of a complex science with a venture capitalist-like hype. It then suggests that, absent additional statutory authority, governmental regulators cannot readily address the risks posed by these products. This regulatory inaction leaves a significant role for the private insurance market, a role that regulators should support in tangible ways outlined in the article.

Original languageEnglish (US)
Pages (from-to)704-713
Number of pages10
JournalJournal of Law, Medicine and Ethics
Issue number4
StatePublished - Dec 2006
Externally publishedYes

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health Policy


Dive into the research topics of 'Nanotechnology: The challenge of regulating known unknowns'. Together they form a unique fingerprint.

Cite this